Advertisement
Advertisement
USNA
USANA Health Sciences Inc
18.56
USDSponsored
+0.42
+2.32%
May 21, 16:00 UTC -4
Closed
After-Market
18.33
-0.23
-1.26%
USNA Earnings Reports
Positive Surprise Ratio
USNA beat 25 of 41 last estimates.
61%
Next Report
Date of Next Report
Jul 20, 2026
Estimate for Q2 26 (Revenue/ EPS)
$239.70M
/$0.43
Implied change from Q1 26 (Revenue/ EPS)
-4.20%
/-29.51%
Implied change from Q2 25 (Revenue/ EPS)
+1.57%
/-41.89%
USANA Health Sciences Inc earnings per share and revenue
On May 05, 2026, USNA reported earnings of 0.61 USD per share (EPS) for Q1 26, beating the estimate of 0.44 USD, resulting in a 35.92% surprise. Revenue reached 250.22 million, compared to an expected 245.81 million, with a 1.79% difference. The market reacted with a +3.89% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 0.43 USD, with revenue projected to reach 239.70 million USD, implying an decrease of -29.51% EPS, and decrease of -4.20% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.29
Actual
-$0.04
Surprise
-113.64%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
VYNE Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.08
Surprise
+56.43%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were USANA Health Sciences Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, USANA Health Sciences Inc reported EPS of $0.61, beating estimates by 35.92%, and revenue of $250.22M, 1.79% above expectations.
How did the market react to USANA Health Sciences Inc's Q1 2026 earnings?
The stock price moved up 3.89%, changed from $19.26 before the earnings release to $20.01 the day after.
When is USANA Health Sciences Inc expected to report next?
The next earning report is scheduled for Jul 20, 2026.
What are the forecasts for USANA Health Sciences Inc's next earnings report?
Based on 3
analysts, USANA Health Sciences Inc is expected to report EPS of $0.43 and revenue of $239.70M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement